Clinical Trials for Neuroendocrine Carcinoma

A Study of 177Lu-DTPA-SC16.56 in People With Neuroendocrine Carcinomas of the Lung and Prostate

NCT ID: NCT06941480

This clinical trial is investigating a new treatment called 177Lu-DTPA-SC16.56 for people with certain types of neuroendocrine tumors, specifically small-cell lung cancer and neuroendocrine prostat...

Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor Malignancies

NCT ID: NCT06577987

This clinical trial is studying a new treatment called CID-078 for patients with advanced solid tumors, which are types of cancer that have spread and are not responding to standard treatments. The...

Use of 68Ga-dotatate PET Scan in Neuroendocrine Carcinoma of the GI Tract

NCT ID: NCT04069299

This clinical trial is studying a special type of imaging test called a 68Ga-dotatate PET scan to learn more about a specific kind of cancer called poorly differentiated neuroendocrine carcinoma, p...

SVV-001 With Nivolumab and Ipilimumab in Patients With Poorly Differentiated Neuroendocrine Carcinomas (NEC) or Well-Differentiated High-Grade Neuroendocrine Tumors (NET)

NCT ID: NCT06889493

This clinical trial is exploring a new treatment option for patients with advanced neuroendocrine tumors (NET) or poorly differentiated neuroendocrine carcinomas (NEC). Specifically, the study aims...

Tarlatamab vs Standard of Care Chemotherapy in Patients With Pre-treated Advanced, Pulmonary or Gastroenteropancreatic Poorly Differentiated Neuroendocrine Carcinomas (NECs)

NCT ID: NCT06937905

This clinical trial is investigating a new treatment called tarlatamab for patients with advanced neuroendocrine carcinoma (NEC), specifically those who have already received chemotherapy. The goal...

A Study in Participants With Advanced Cancers Associated With Expression of DLL3 (MK-6070-001/HPN328-4001)

NCT ID: NCT04471727

This clinical trial is studying a new treatment called MK-6070 for patients with advanced cancers, specifically those related to small-cell lung cancer and neuroendocrine tumors that express a prot...

Rediscovering Biomarkers for the Diagnosis and Early Treatment Response in NEN (REBORN)

NCT ID: NCT04464122

The REBORN trial is a study looking at new ways to diagnose and monitor the treatment of neuroendocrine tumors (NENs), which are a type of cancer that can arise from hormone-producing cells. Resear...

Ph I/II Trial of Systemic VSV-IFNβ-NIS in Combination With Checkpoint Inhibitor Therapy in Patients With Select Solid Tumors

NCT ID: NCT03647163

This clinical trial is investigating a new treatment approach for patients with advanced solid tumors, specifically focusing on non-small cell lung cancer (NSCLC) and neuroendocrine carcinoma (NEC)...

Clinical Application of the J-PET Scanner Prototype

NCT ID: NCT06242119

This clinical trial is exploring a new type of imaging technology called the J-PET scanner, which is designed to help doctors better diagnose certain conditions like prostate cancer and other relat...

Study of ZG006 in Participants With Small Cell Lung Cancer or Neuroendocrine Carcinoma

NCT ID: NCT05978284

This clinical trial is studying a new treatment called ZG006 for patients with small cell lung cancer or neuroendocrine carcinoma who have not had any standard treatment options available, or who w...

Dose Escalation Study of ZG006 in Participants With Advanced Small Cell Lung Cancer or Neuroendocrine Carcinoma, Followed by Dose Expansion Study in Participants With Neuroendocrine Carcinoma.

NCT ID: NCT06440057

This clinical trial is testing a new treatment called ZG006 for patients with advanced small cell lung cancer or neuroendocrine carcinoma, a type of cancer that affects hormone-producing cells. The...

Dostarlimab for Locally Advanced or Metastatic Cancer (non-colorectal/non-endometrial) with Tumor DMMR/MSI

NCT ID: NCT06333314

This clinical trial is studying the effectiveness of a new immunotherapy drug called dostarlimab for patients with certain types of advanced or metastatic cancers that are not colorectal or endomet...

Iadademstat in Combination With Paclitaxel in Relapsed/Refractory SCLC and Extrapulmonary High Grade NET

NCT ID: NCT05420636

This clinical trial is investigating a new treatment called iadademstat, combined with a chemotherapy drug called paclitaxel, for patients with relapsed or hard-to-treat small-cell lung cancer (SCL...

Study of ZG005 in Combination With Etoposide and Cisplatin in Participants With Advanced Neuroendocrine Carcinoma.

NCT ID: NCT06372626

This clinical trial is studying a new treatment called ZG005, which is being tested in combination with two other drugs, Etoposide and Cisplatin, for patients with advanced neuroendocrine carcinoma...

Simultaneous Hyperpolarized [1-13C]Pyruvate and 18F-FDG PET/MRS in Cancer Patients

NCT ID: NCT05396118

PrognostIc and Predictive Factors in Unresectable Locally Advanced NEC and MANEC

NCT ID: NCT06400654

This clinical trial is studying a rare and aggressive type of cancer called neuroendocrine carcinoma (NEC) and mixed adeno-neuroendocrine carcinoma (MANEC). These cancers are challenging to treat d...

RegisterNET - A Registry for Neuroendocrine Tumors in the USA

NCT ID: NCT02270567

Neuroendocrine Transformation in RB1/TP53 Inactivated NSCLC

NCT ID: NCT06369181

This clinical trial is studying a specific type of lung cancer known as non-small cell lung cancer (NSCLC), particularly focusing on patients who have changes in certain genes (RB1 and TP53) that m...

The Molecular Screening Study for the Umbrella Trial (SUKSES) in Relapsed Small Cell Lung Cancer Patients [SUKSES-S]

NCT ID: NCT02688894

The SUKSES-S trial is focused on understanding the genetic makeup of small cell lung cancer, particularly in patients whose cancer has come back after treatment. This study does not involve testing...

Dual 64Cu-DOTATATE and 18F-FDG PET/CT Imaging of Patients With Neuroendocrine Neoplasms

NCT ID: NCT05709171